Hydroxychloroquine serum concentration in coronavirus disease 2019 (COVID-19) patients: a retrospective study

Algeria has adopted a therapeutic protocol using hydroxychloroquine (HCQ) as a first-line treatment for patients with coronavirus disease 2019 (COVID-19). The administration of HCQ must be accompanied by appropriate cardiac and therapeutic pharmacological monitoring to avoid side effects and toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zohra, Saadi Fatima, Nassima, Lachgueur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635677/
https://www.ncbi.nlm.nih.gov/pubmed/34868713
http://dx.doi.org/10.1080/20961790.2021.1936896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635677/
https://www.ncbi.nlm.nih.gov/pubmed/34868713
http://dx.doi.org/10.1080/20961790.2021.1936896

Ejemplares similares